Cidara Therapeutics Inc (CDTX)

Jun 19, 2025

(CDTX) Proactive Strategies - news.stocktradersdaily.com

Jun 19, 2025

Jun 18, 2025

Cidara Therapeutics (CDTX) Receives Buy Rating from HC Wainwrigh - GuruFocus

Jun 18, 2025

Jun 18, 2025

H.C. Wainwright assumes coverage on Cidara stock with buy rating By Investing.com - Investing.com UK

Jun 18, 2025

Jun 18, 2025

H.C. Wainwright Initiates Coverage on Cidara Therapeutics (CDTX) with Strong Outlook | CDTX Stock News - GuruFocus

Jun 18, 2025

Jun 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 11, 2025

Jun 10, 2025

Cidara Therapeutics (CDTX) Reiterates Overweight Rating by Canto - GuruFocus

Jun 10, 2025

Jun 06, 2025

(CDTX) Investment Analysis - news.stocktradersdaily.com

Jun 06, 2025

Jun 06, 2025

Millennium Management LLC Raises Stock Holdings in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

Jun 06, 2025

Jun 05, 2025

Cidara Therapeutics stock maintains strong rating at Citizens JMP By Investing.com - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $36.00 at Needham & Company LLC - Defense World

Jun 05, 2025

Jun 04, 2025

Insider Buying: Chrysa Mineo Acquires Shares of Cidara Therapeutics Inc (CDTX) - GuruFocus

Jun 04, 2025

Jun 04, 2025

Needham raises Cidara Therapeutics stock price target to $36 - Investing.com

Jun 04, 2025

Jun 04, 2025

Cidara Therapeutics (CDTX) Price Target Raised by Needham | CDTX Stock News - GuruFocus

Jun 04, 2025

Jun 03, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given Market Outperform Rating at JMP Securities - Defense World

Jun 03, 2025

Jun 02, 2025

Cidara Therapeutics (CDTX) Maintains Market Outperform Rating | CDTX Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

12,714 Shares in Cidara Therapeutics, Inc. (NASDAQ:CDTX) Purchased by Jane Street Group LLC - Defense World

Jun 02, 2025

May 30, 2025

Northern Trust Corp Has $913,000 Stock Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

May 30, 2025

May 29, 2025

Cidara Therapeutics Stock (CDTX): A Notable Contender in Antivirals - Value The Markets

May 29, 2025

May 28, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given “Market Outperform” Rating at JMP Securities - Defense World

May 28, 2025

May 27, 2025

JMP Securities Reiterates Market Outperform Rating for Cidara Therapeutics (CDTX) | CDTX Stock News - GuruFocus

May 27, 2025

May 27, 2025

Cidara stock target holds at $47 by JMP on trial confidence - Investing.com Canada

May 27, 2025

May 27, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Analysts - Defense World

May 27, 2025

May 27, 2025

(CDTX) On The My Stocks Page - news.stocktradersdaily.com

May 27, 2025

May 25, 2025

Cidara Therapeutics: All Stars Aligning In Favor Of CD388 (NASDAQ:CDTX) - Seeking Alpha

May 25, 2025

May 25, 2025

Royal Bank of Canada Increases Cidara Therapeutics (NASDAQ:CDTX) Price Target to $35.00 - Defense World

May 25, 2025

May 25, 2025

Cidara Therapeutics (NASDAQ:CDTX) Earns Buy Rating from Needham & Company LLC - Defense World

May 25, 2025

May 24, 2025

Analysts Are Bullish on These Healthcare Stocks: Cidara Therapeutics (CDTX), Merus (MRUS) - The Globe and Mail

May 24, 2025

May 23, 2025

Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RB - GuruFocus

May 23, 2025

May 23, 2025

Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RBC Capital | CDTX Stock News - GuruFocus

May 23, 2025

May 23, 2025

RBC Capital Ups Price Target for Cidara Therapeutics (CDTX) Amid Optimism | CDTX Stock News - GuruFocus

May 23, 2025

May 23, 2025

Cidara Therapeutics (CDTX): Analyst Reiterates Buy Rating | CDTX Stock News - GuruFocus

May 23, 2025

May 23, 2025

RBC Raises Price Target on Cidara Therapeutics to $35 From $31, Keeps Outperform, Speculative Risk - marketscreener.com

May 23, 2025

May 22, 2025

Transcript : Cidara Therapeutics, Inc.Special Call - marketscreener.com

May 22, 2025

May 20, 2025

Seasonal Influenza Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cidara, Moderna, SAB Therapeutics, Sinovac Biotech, Novartis - Barchart.com

May 20, 2025

May 20, 2025

Seasonal Influenza Market to Reach New Heights in Growth by 2034, - openPR.com

May 20, 2025

May 18, 2025

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World

May 18, 2025

May 16, 2025

CDTX Stock Price and Chart — NASDAQ:CDTX - TradingView

May 16, 2025

May 16, 2025

When (CDTX) Moves Investors should Listen - news.stocktradersdaily.com

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenh - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025

May 16, 2025

Cidara Therapeutics price target raised to $50 from $35 at Guggenheim - TipRanks

May 16, 2025

May 15, 2025

Cidara Therapeutics to Host Virtual R&D Day to Discuss - GlobeNewswire

May 15, 2025

May 15, 2025

Revolutionary Once-Per-Year Universal Flu Prevention: Cidara Unveils Phase 2b Trial Updates at R&D Day - Stock Titan

May 15, 2025

May 15, 2025

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025 - The Manila Times

May 15, 2025

May 13, 2025

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 13, 2025

May 12, 2025

Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call - MSN

May 12, 2025

May 12, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00 - Defense World

May 12, 2025

May 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, JMP Securities Analyst Says - Defense World

May 11, 2025

May 11, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 10, 2025

Guggenheim Raises Price Target for Cidara Therapeutics (CDTX) to $35.00 | CDTX Stock News - GuruFocus

May 10, 2025

May 10, 2025

StockNews.com Upgrades Cidara Therapeutics (NASDAQ:CDTX) to Sell - Defense World

May 10, 2025